Replies to post #387955 on Innovation Pharmaceuticals Inc (IPIX)

[backtoreality]

From what the company spokesman stated, the mindset of big Pharmaceutical companies now is taking advantage of the poor little biotechnology that thanks to Corona had their drugs analyzed to the point that Brilicin was in a series of computer comparisons and came out in the upper echelon. How much DD does some guy that used to be someone now messaging in stock chat rooms need to do to see a flashing flicking sign saying Brilicidin

[Here Today]

Would not even know what they would offer, but it definitely would be lowballed since the share price is beat down. If they were to offer $4.00 per share for Everything excluding the indication and method that currently is licensed to another Pharma, I feel that would be a win right now in my opinion. It would be a loss for all the Longs who have not averaged down as of late, but for the newbie investors and for those that have averaged down and invested more, it will be a very nice win. I’ve personally averaged down myself greatly since I feel Brilacidin can one day be a platform type drug, and Kevetrin can one day be bigger than Keytruda. But at this present moment in time and where the company’s finances are, I would be happy to see the $4.00 per share buyout as things stand now. Just my opinion. If government funding or another form of non-dilutive funding comes along, than all bets are off.